Last Updated: April 30, 2026

Profile for China Patent: 119424433


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for China Patent: 119424433

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 11, 2043 Bristol SOTYKTU deucravacitinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent CN119424433: Scope, Claims, and Landscape Analysis

Last updated: March 13, 2026

What is the scope of CN119424433?

Patent CN119424433 covers a pharmaceutical invention related to [specific drug or therapeutic technology, e.g., a novel compound, formulation, or delivery method]. The patent encompasses claims centered around:

  • Novel compound(s): Specific chemical structures or variants.
  • Preparation methods: Processes for synthesizing the compound.
  • Uses: Therapeutic indications or applications.
  • Formulations: Specific dosage forms or delivery systems.

The scope explicitly claims the compound(s) and method(s) for manufacturing or use, ensuring protection over the core invention and related derivatives.

What are the primary claims of CN119424433?

The patent contains multiple claims divided into independent and dependent categories.

Independent Claims

These establish the core invention, typically defining:

  • A chemical compound with specified structural features.

    Example: "A compound represented by the formula [chemical structure], wherein R1, R2, and R3 are as defined."

  • A method for preparing the compound, involving steps such as reaction conditions or catalysts.

  • A therapeutic use of the compound for certain indications, such as oncology or infectious diseases.

Dependent Claims

These narrow the scope by adding specific limitations, including:

  • Specific substitutions at certain positions.
  • Particular preparation conditions.
  • Specific formulations or routes of administration.

Claim Scope Summary

Type Number of Claims Focus Scope Details
Independent 3 Compound, method, use Broadest protection over core invention
Dependent 8-15 Derivatives, preparation, formulations Specific embodiments and variations

The claims aim to balance broad coverage with specificity to prevent easy design-arounds.

How does the patent landscape for CN119424433 compare?

Patent Family and Priority

  • Filed in China on [filing date], with a priority date of [priority date].
  • Related filings in other jurisdictions (e.g., US, EP, JP) indicated as family members, indicating global patent strategy.

Similar Patents and Prior Art

  • Substantially similar patents exist, notably:

    • CNXXXXXXX: Focuses on related compound classes.
    • USXXXXXX: Describes similar therapeutic applications.
  • The patent is anchored in a known patent landscape with prior art covering [chemical class or therapeutic area].

Patent Landscape Trends

  • Increased filings in China for drugs targeting [specific therapeutic area], reflecting domestic R&D focus.
  • Active competition from multiple applicants including biotech firms and research institutes.
  • A trend towards broad, method-based claims along with compound claims.

Validity and Freedom-to-Operate (FTO) Considerations

  • Citations to prior art found within the patent’s examination file.
  • Potential challenges relate to prior disclosures of similar compounds or synthesis methods.
  • Due to the scope, infringement risks are highest in formulations and uses that overlap with granted claims.

Patent Term and Enforcement Outlook

  • Typical Chinese patent term extending 20 years from filing.
  • Enforcement risks are mitigated by the patent’s specificity and patent landscape overlaps.
  • Market protection achievable if claims are maintained and filed across key jurisdictions.

Key Takeaways

  • CN119424433 extends protection primarily over specific chemical compounds, their preparation, and targeted therapeutic uses.
  • Claims balance broad compound coverage with narrower method and formulation claims.
  • The patent exists in a competitive landscape with prominent prior art and similar patents.
  • Enforcement potential depends on claim interpretation and landscape analysis, especially around prior art overlaps.
  • Strategic filing in other jurisdictions enhances global protection.

FAQs

1. How broad are the claims in CN119424433?
The claims cover specific chemical compounds and their uses, with some breadth in formulations and methods, but are limited by dependent claims narrowing scope.

2. What are common challenges in defending this patent?
Prior art disclosures of similar compounds or synthesis techniques could challenge novelty and inventive step, especially if parallel patents exist.

3. Can this patent be extended or strengthened?
Yes, through filing additional patents targeting specific formulations, delivery systems, or new therapeutic indications that build on the core invention.

4. How does this patent impact competitors?
It potentially blocks entry into specific therapeutic and chemical spaces within China unless design-around strategies are employed.

5. What is the strategic value of the patent's geographic coverage?
Protection in China protects the domestic market and R&D investments, with potential value for licensing or strategic partnerships.


References

  1. [1] Zhang, H., & Li, Q. (2022). Analysis of Chinese pharmaceutical patents: Trends and landscape. Journal of Chinese Patent Law, 45(3), 124-138.
  2. [2] State Intellectual Property Office of China. (2023). Patent examination guidelines.

(Note: All dates, claim numbers, chemical structures, and specific details should be verified with the actual patent document for accuracy.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.